Dr Louis Jacques, Director for the Coverage and Analysis Group at the Centers for Medicare and Medicaid Services, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âAchieving reimbursement for regenerative medicine products in the USA.'
In his presentation, Louis gives an overview on:
- Understanding the mechanisms of reimbursement and variety of payers in the USA
- Using this knowledge to formulate a successful USA reimbursement strategy for regenerative medicine: considering coverage, payment, coding, cost of goods and clinical study design
- Considering important considerations for the design of clinical studies to satisfy both the payers and the FDA
- Identifying key elements of a successful company strategy for RM product reimbursement
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.